Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: effect of specific prognostic markers on survival and development of a prognostic model.
Authors
Scarisbrick, JPrince, H
Vermeer, M
Quaglino, P
Horwitz, S
Porcu, P
Stadler, R
Wood, G
Beylot-Barry, M
Pham-Ledard, A
Foss, F
Girardi, M
Bagot, M
Michel, L
Battistella, M
Guitart, J
Kuzel, T
Martinez-Escala, M
Estrach, T
Papadavid, E
Antoniou, C
Rigopoulos, D
Nikolaou, V
Sugaya, M
Miyagaki, T
Gniadecki, R
Sanches, J
Cury-Martins, J
Miyashiro, D
Servitje, O
Muniesa, C
Berti, E
Onida, F
Corti, L
Hodak, E
Amitay-Laish, I
Ortiz-Romero, P
Rodríguez-Peralto, J
Knobler, R
Porkert, S
Bauer, W
Pimpinelli, N
Grandi, V
Cowan, Richard A
Rook, A
Kim, E
Pileri, A
Patrizi, A
Pujol, R
Wong, H
Tyler, K
Stranzenbach, R
Querfeld, C
Fava, P
Maule, M
Willemze, R
Evison, F
Morris, S
Twigger, R
Talpur, R
Kim, J
Ognibene, G
Li, S
Tavallaee, M
Hoppe, R
Duvic, M
Whittaker, S
Kim, Y
Affiliation
University Hospital Birmingham, BirminghamIssue Date
2015-10-05
Metadata
Show full item recordAbstract
Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggressive lymphomas with a median survival of 1 to 5 years. Clinical management is stage based; however, there is wide range of outcome within stages. Published prognostic studies in MF/SS have been single-center trials. Because of the rarity of MF/SS, only a large collaboration would power a study to identify independent prognostic markers.Citation
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. 2015: J. Clin. Oncol.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2015.61.7142PubMed ID
26438120Type
ArticleLanguage
enISSN
1527-7755ae974a485f413a2113503eed53cd6c53
10.1200/JCO.2015.61.7142
Scopus Count
Collections
Related articles
- Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
- Authors: Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ
- Issue date: 2010 Nov 1
- A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
- Authors: Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, Wedgeworth E, Mitchell TJ, Cox M, Ferreira S, Liu P, Robson A, Calonje E, Stefanato CM, Wilkins B, Scarisbrick J, Wain EM, Child F, Morris S, Duvic M, Whittaker SJ
- Issue date: 2013 Sep
- Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatment.
- Authors: Alberti-Violetti S, Talpur R, Schlichte M, Sui D, Duvic M
- Issue date: 2015 Jun
- Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.
- Authors: Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R
- Issue date: 1998 Aug 15
- Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.
- Authors: Lebowitz E, Geller S, Flores E, Pulitzer M, Horwitz S, Moskowitz A, Kheterpal M, Myskowski PL
- Issue date: 2019 Jan